NEWYou can now listen to Fox News articles! U.S. lawmakers are growing concerned with ongoing …
Read More »New endometrial cancer drug boosts survival in phase 3 trial
NEWYou can now listen to Fox News articles! A new treatment for endometrial cancer demonstrated strong potential in a Phase 3 clinical trial. Drugmaker Merck announced Monday that the investigational drug sacituzumab tirumotecan (sac-TMT) met its “primary endpoints” of overall survival and progression-free survival in patients with advanced or recurrent …
Read More »
Latest Breaking News Online News Portal




































